JCO-话题@MedSci

#JCO#

724篇内容 | 6971人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1891348, encodeId=0a861891348e6, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：阿扎胞苷单药或与来那度胺或伏立诺他联合用药治疗高风险骨髓增生异常综合征或慢性单核细胞白血病, objectType=article, longId=98626, objectId=ca039862681, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca039862681, replyNumber=0, likeNumber=68, createdTime=2017-09-29, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca039862681, moduleTitle=JCO：阿扎胞苷单药或与来那度胺或伏立诺他联合用药治疗高风险骨髓增生异常综合征或慢性单核细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca039862681)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891378, encodeId=39da18913e8e3, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：晚期乳头状肾细胞癌患者使用savolitinib的生物标志物（II期试验）, objectType=article, longId=103418, objectId=36731034183e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36731034183e, replyNumber=0, likeNumber=60, createdTime=2017-10-05, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36731034183e, moduleTitle=JCO：晚期乳头状肾细胞癌患者使用savolitinib的生物标志物（II期试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36731034183e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891436, encodeId=82d01891436d0, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=【盘点】JCO 杂志8月第3期精选文章一览, objectType=article, longId=111149, objectId=edcd1111491d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edcd1111491d, replyNumber=0, likeNumber=60, createdTime=2017-12-08, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edcd1111491d, moduleTitle=【盘点】JCO 杂志8月第3期精选文章一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edcd1111491d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891387, encodeId=b9e3189138e6e, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO:NSAID可显着改善KRAS野生型患者的生存, objectType=article, longId=104813, objectId=403e10481310, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=403e10481310, replyNumber=0, likeNumber=67, createdTime=2018-06-16, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=403e10481310, moduleTitle=JCO:NSAID可显着改善KRAS野生型患者的生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=403e10481310)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891354, encodeId=dc9b189135489, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：哪种量表评估儿童顺铂治疗所致耳毒性更好？, objectType=article, longId=99684, objectId=34fc996846e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34fc996846e, replyNumber=0, likeNumber=61, createdTime=2017-06-26, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34fc996846e, moduleTitle=JCO：哪种量表评估儿童顺铂治疗所致耳毒性更好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34fc996846e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891368, encodeId=94e518913689b, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：化疗引起的周围神经病变在化疗后对机体功能的影响需关注！, objectType=article, longId=101349, objectId=0175101349ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0175101349ee, replyNumber=0, likeNumber=76, createdTime=2018-03-12, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0175101349ee, moduleTitle=JCO：化疗引起的周围神经病变在化疗后对机体功能的影响需关注！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0175101349ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891409, encodeId=4c8c189140937, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：不同亚型乳腺癌保乳术后放疗反应如何？, objectType=article, longId=107413, objectId=c05310e413b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c05310e413b6, replyNumber=0, likeNumber=65, createdTime=2017-09-18, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c05310e413b6, moduleTitle=JCO：不同亚型乳腺癌保乳术后放疗反应如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c05310e413b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891312, encodeId=fe2718913121b, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：R-HDS方案不能显著改善高危弥漫性大B细胞淋巴瘤患者的预后, objectType=article, longId=81966, objectId=15ec819669e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15ec819669e, replyNumber=0, likeNumber=72, createdTime=2016-12-18, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15ec819669e, moduleTitle=JCO：R-HDS方案不能显著改善高危弥漫性大B细胞淋巴瘤患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15ec819669e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891313, encodeId=bfe01891313be, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：RADIANT-3研究：随机三期临床研究探索依维莫司治疗晚期胰腺内分泌瘤患者的OS与循环生物标志物, objectType=article, longId=81989, objectId=52d8819890c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52d8819890c, replyNumber=0, likeNumber=65, createdTime=2017-03-11, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52d8819890c, moduleTitle=JCO：RADIANT-3研究：随机三期临床研究探索依维莫司治疗晚期胰腺内分泌瘤患者的OS与循环生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52d8819890c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891435, encodeId=d97d1891435d0, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=【盘点】JCO 杂志8月第2期精选文章一览, objectType=article, longId=111111, objectId=9d3f1111117f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d3f1111117f, replyNumber=0, likeNumber=71, createdTime=2017-09-21, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d3f1111117f, moduleTitle=【盘点】JCO 杂志8月第2期精选文章一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d3f1111117f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891408, encodeId=cbb4189140885, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：止吐药：美国临床肿瘤学临床实践指南的更新, objectType=article, longId=107407, objectId=8f1e10e407d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f1e10e407d7, replyNumber=0, likeNumber=62, createdTime=2018-02-15, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f1e10e407d7, moduleTitle=JCO：止吐药：美国临床肿瘤学临床实践指南的更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f1e10e407d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891364, encodeId=6b7f18913649c, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：抗体偶联药物——IMMU-132治疗晚期非小细胞肺癌的安全性及有效性, objectType=article, longId=100331, objectId=61301003316f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61301003316f, replyNumber=0, likeNumber=149, createdTime=2018-04-11, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61301003316f, moduleTitle=JCO：抗体偶联药物——IMMU-132治疗晚期非小细胞肺癌的安全性及有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61301003316f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891427, encodeId=c156189142e1a, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：吉西他滨+厄洛替尼辅助治疗胰腺导管腺癌，患者能否获益？, objectType=article, longId=110988, objectId=0e3c110988f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e3c110988f4, replyNumber=0, likeNumber=74, createdTime=2018-07-05, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e3c110988f4, moduleTitle=JCO：吉西他滨+厄洛替尼辅助治疗胰腺导管腺癌，患者能否获益？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e3c110988f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891322, encodeId=c69e1891322ec, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：如何管理肥胖癌症患者（综述）, objectType=article, longId=83464, objectId=ec4283464b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec4283464b1, replyNumber=0, likeNumber=85, createdTime=2016-12-05, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec4283464b1, moduleTitle=JCO：如何管理肥胖癌症患者（综述）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec4283464b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891353, encodeId=001e1891353ce, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：EGFR突变型NSCLC脑转移患者的治疗策略, objectType=article, longId=99333, objectId=ac4999333a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac4999333a5, replyNumber=0, likeNumber=62, createdTime=2017-08-08, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac4999333a5, moduleTitle=JCO：EGFR突变型NSCLC脑转移患者的治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac4999333a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891355, encodeId=86e218913553c, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：ERCC1 蛋白能预测非小细胞肺癌患者化疗的结局？, objectType=article, longId=99685, objectId=b94499685fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b94499685fe, replyNumber=0, likeNumber=63, createdTime=2018-01-27, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b94499685fe, moduleTitle=JCO：ERCC1 蛋白能预测非小细胞肺癌患者化疗的结局？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b94499685fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891328, encodeId=6a2b189132853, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：关注“化疗脑”！化疗后患者或可遭受认知障碍的困扰, objectType=article, longId=86866, objectId=3b2286866b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b2286866b9, replyNumber=0, likeNumber=72, createdTime=2017-02-08, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b2286866b9, moduleTitle=JCO：关注“化疗脑”！化疗后患者或可遭受认知障碍的困扰, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b2286866b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891383, encodeId=bcfc18913833e, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：Nivolumab治疗晚期黑色素瘤能获得更长的持续缓解时间（CheckMate 037）, objectType=article, longId=104621, objectId=bd5810462170, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd5810462170, replyNumber=0, likeNumber=74, createdTime=2017-08-16, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd5810462170, moduleTitle=JCO：Nivolumab治疗晚期黑色素瘤能获得更长的持续缓解时间（CheckMate 037）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd5810462170)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891311, encodeId=9b39189131182, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：Pembrolizumab治疗黑色素瘤患者中PD-L1表达量与缓解时间呈正相关（KEYNOTE-001）, objectType=article, longId=81794, objectId=916481e9401, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=916481e9401, replyNumber=0, likeNumber=70, createdTime=2016-12-07, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=916481e9401, moduleTitle=JCO：Pembrolizumab治疗黑色素瘤患者中PD-L1表达量与缓解时间呈正相关（KEYNOTE-001）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=916481e9401)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1891345, encodeId=e4bf189134598, content=<a href='/topic/show?id=25b0102e2df' target=_blank style='color:#2F92EE;'>#JCO#</a>, objectTitle=JCO：基因检测是否影响早期乳腺癌的临床决策, objectType=article, longId=98100, objectId=890498100ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=890498100ca, replyNumber=0, likeNumber=71, createdTime=2017-09-14, rootId=0, userName=lidong40, userId=6da1120, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=890498100ca, moduleTitle=JCO：基因检测是否影响早期乳腺癌的临床决策, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=890498100ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

JCO

2020-05-29

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：阿扎胞苷单药或与来那度胺或伏立诺他联合用药治疗高风险骨髓增生异常综合征或慢性单核细胞白血病

2017-09-29

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：晚期乳头状肾细胞癌患者使用savolitinib的生物标志物（II期试验）

2017-10-05

zhouqu_8 (审核中...)

前往app查看评论内容

#JCO#

【盘点】JCO 杂志8月第3期精选文章一览

2017-12-08

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO:NSAID可显着改善KRAS野生型患者的生存

2018-06-16

zhaojie88 (审核中...)

前往app查看评论内容

#JCO#

JCO：哪种量表评估儿童顺铂治疗所致耳毒性更好？

2017-06-26

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：化疗引起的周围神经病变在化疗后对机体功能的影响需关注！

2018-03-12

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：不同亚型乳腺癌保乳术后放疗反应如何？

2017-09-18

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：R-HDS方案不能显著改善高危弥漫性大B细胞淋巴瘤患者的预后

2016-12-18

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：RADIANT-3研究：随机三期临床研究探索依维莫司治疗晚期胰腺内分泌瘤患者的OS与循环生物标志物

2017-03-11

zhouqu_8 (审核中...)

前往app查看评论内容

#JCO#

【盘点】JCO 杂志8月第2期精选文章一览

2017-09-21

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：止吐药：美国临床肿瘤学临床实践指南的更新

2018-02-15

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：抗体偶联药物——IMMU-132治疗晚期非小细胞肺癌的安全性及有效性

2018-04-11

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：吉西他滨+厄洛替尼辅助治疗胰腺导管腺癌，患者能否获益？

2018-07-05

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：如何管理肥胖癌症患者（综述）

2016-12-05

zhaojie88 (审核中...)

前往app查看评论内容

#JCO#

JCO：EGFR突变型NSCLC脑转移患者的治疗策略

2017-08-08

zhaojie88 (审核中...)

前往app查看评论内容

#JCO#

JCO：ERCC1 蛋白能预测非小细胞肺癌患者化疗的结局？

2018-01-27

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：关注“化疗脑”！化疗后患者或可遭受认知障碍的困扰

2017-02-08

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：Nivolumab治疗晚期黑色素瘤能获得更长的持续缓解时间（CheckMate 037）

2017-08-16

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：Pembrolizumab治疗黑色素瘤患者中PD-L1表达量与缓解时间呈正相关（KEYNOTE-001）

2016-12-07

lidong40 (审核中...)

前往app查看评论内容

#JCO#

JCO：基因检测是否影响早期乳腺癌的临床决策

2017-09-14

科室
- - 订阅+
  - 更多科室
工具
服务